Guidelines for the management of patients with acute myocardial infarction

Journal of Thrombosis and Thrombolysis

Volumn 5, Issue 1, 1998, Pages 73-81

  Becker, Richard C ^a   Spencer, Fred ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; FIBRINOLYTIC THERAPY; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031931944     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008809723703     Document Type: Review

References (3)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE, Weaver WD and the Task Force Members. ACC. AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28: 1328-1428.
2. Fuster V, Dyken ML, Vokonas PS, Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1993;87:659-685.
3. Fourth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Chest 1995; 108(suppl):225S-522S.